Prospective Observational Study of Maternal and Fetal Outcome in COVID-19 Patients Admitted in a Tertiary Care Teaching Hospital MIMS, Mandya

ABSTRACT

Introduction: Corona Virus Disease 2019 (COVID-19) is an infectious disease caused by SARS-COV-2. First identified in December 19 in Wuhan, China On March 12,2020, WHO announced corona virus outbreak as pandemic. Till September 14, in India >48,50,887 confirmed cases, >9,90,502 active cases, >37,79,927 recovered cases reported. In karnataka 4,59,445 confirmed, 99,203 active, 3,52,958 recovered, 7265 death reported. Aim: To study maternal and fetal outcome in COVID-19 positive pregnant patients admitted in MIMS, Mandya (from 1s t wave to 3r d wave). Materials and methods: This is a prospective study conducted in the Department of OBG, MIMS, Mandya, of a study period of 15 months from June 2020 to November 2021. All cases of confirmed COVID- 19 patients admitted in the Department of OBG are included in the study period ,using medical case records, OT registered - age ,parity ,mode of presentation, investigations, management and outcome of delivery were observed among the COVID-19 patients Results: Out of 216 admissions in 1 s t wave 139 cases delivered and in these 84 (60.4%) vaginal deliveries and 55 (39.5%) c-section ,among which 1 VBAC, 1 breech, 1 vaccum, 3 PPH, 2 IUD, 1 maternal death and 40 NICU admissions and among which 4 babies were positive and 1 neonatal death. During 2nd wave, out of 355 admissions 168 delivered and in these 98(58.3%) vaginal deliveries and 70 (41.6%) c-section, among them 8 vaccum deliveries, 4 IUD, 1 breech, 1 VBAC, 4 PPH , 1 MRP, 5 MVA and 1 ectopic pregnancy and 10 maternal death and 15 NICU admissions among them 8 COVID-19 positive babies and 1 neonatal death. In the emerge of 3r d wave 1 case we have documented and it is LSCS on 2/11/21 baby COVID-19 negative. Conclusion: Compared to 1st wave and 2nd wave there is increase in disease severity and number of cases. Burden of disease has drastically increased. Early diagnosis and prompt treatment can reduce the mortality rate in COVID-19 patients.